Literature DB >> 2255100

Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan.

I Kato1, T Kuroishi, S Tominaga.   

Abstract

Recent time trends (1979-1987) and geographical distributions in mortalities from subsites of cancers of the hepato-biliary-pancreatic system have been investigated on the basis of the vital statistics of Japan. The corrected age-adjusted mortality rates (CAAMRs) were calculated to eliminate the influence of the proportion of subsite-unknown cancers. During the above period, the CAAMR for intrahepatic bile duct cancer increased by a relatively high extent (2.0-fold in males and 1.67-fold in females), and those for cancers of the gallbladder, extrahepatic bile duct and pancreas (head and other parts) increased to a moderate extent (1.2-1.4-fold). The CAAMR for primary liver cancer showed an increasing trend in males and a decreasing trend in females. The CAAMR for cancer of the ampulla Vater changed little during the period. A clear cluster of prefectures with high CAAMRs was observed in the northern part of Japan for cancers of the extrahepatic bile duct and pancreatic head. Clusters of prefectures with high CAAMRs for cancer of the gallbladder and ampulla Vater were observed in the mid-northern part of Japan, especially on the Japan Sea side. The CAAMR for primary liver cancer was high in the Island of Kyushu and some western parts of Japan, and low in the northern part of Honshu Island. No clear clusters of prefectures with high CAAMRs were observed for cancers of the intrahepatic bile duct and pancreas, other than for the pancreatic head.

Entities:  

Mesh:

Year:  1990        PMID: 2255100

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  8 in total

1.  Changes in pancreatic cancer mortality, period patterns, and birth cohort patterns in Japan: analysis of mortality data in the period 1968-2002.

Authors:  Takayuki Seino; Hiroto Nakadaira; Kazuo Endoh; Masaharu Yamamoto
Journal:  Environ Health Prev Med       Date:  2008-05-24       Impact factor: 3.674

2.  Small intestinal metastasis from intrahepatic cholangiocarcinoma: report of a case.

Authors:  Hironori Hayashi; Takashi Tani; Hidehiro Tajima; Yasuhiro Shoji; Shiro Terai; Ichiro Onishi; Hiroyuki Takamura; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

3.  CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells.

Authors:  Sungmin Baek; Yong-Whan Lee; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Sae-Ock Oh
Journal:  Anat Cell Biol       Date:  2010-06-30

4.  WTAP regulates migration and invasion of cholangiocarcinoma cells.

Authors:  Hong-Jae Jo; Hye-Eun Shim; Myoung-Eun Han; Hyun-Jung Kim; Ki-Sun Kim; Sungmin Baek; Kyung-Un Choi; Gi-Yeong Hur; Sae-Ock Oh
Journal:  J Gastroenterol       Date:  2013-01-25       Impact factor: 7.527

Review 5.  Current status of intrahepatic cholangiocarcinoma.

Authors:  Jian Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

Review 6.  Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.

Authors:  Kelly J Lafaro; David Cosgrove; Jean-Francois H Geschwind; Ihab Kamel; Joseph M Herman; Timothy M Pawlik
Journal:  Gastroenterol Res Pract       Date:  2015-05-19       Impact factor: 2.260

7.  Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.

Authors:  Mai Utada; Yuko Ohno; Tomoko Tamaki; Tomotaka Sobue; Ginji Endo
Journal:  J Epidemiol       Date:  2014-03-07       Impact factor: 3.211

8.  Geographic clustering patterns in mortality from biliary tract cancer in Japan.

Authors:  K Kodama; H Nakadaira; K Endoh; M Yamamoto
Journal:  Jpn J Cancer Res       Date:  1998-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.